Future Oncology

Articles Available on Medscape

• Actual Benefit of Chemo-Hormonal Therapy in Non-Castrate Metastatic Prostate Cancer
  Which treatment combination is most effective for non-castrate metastatic prostate cancer?

  May 07, 2015

• Patient Pathway for Breast Cancer: Turning Points and Future Aspirations
  Improved survival from breast cancer can be attributed to a number of advances in the patient pathway from screening to advanced disease. What's next?

  May 07, 2015

• FISH in Triple-negative Breast Cancer: A Possible Strategy for the Future?
  How will using the FISH assay in TNBCs produce drastic changes in clinical practice?

  May 06, 2015

• Current and Future Targeted Therapies for Non-Small-Cell Lung Cancers With Aberrant EGF Receptors
  Find out about current molecular targets that have therapies available and other targets for which therapies will be available in the near future.

  May 06, 2015

• Toward a Better Management of Older Patients With Acute Myeloid Leukemia
  Significant progress has been made in the treatment of younger AML patients, but survival rates among older patients are poor.

  May 05, 2015

Table of Contents

2023 -

• Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer. 

  February 23, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Intersectionality in patients with cancer: who should care and why? 

  February 20, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Safety differences across androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancer. 

  February 16, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Afatinib for the treatment of non-small-cell lung cancer with unusual EGFR mutations: a plain language summary. 

  February 16, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Circulating DNA methylation profile improves the accuracy of serum biomarkers for the detection of nonmetastatic hepatocellular carcinoma. 

  February 14, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma. 

  February 13, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Efficacy and safety of immune checkpoint inhibitors combined with recombinant human endostatin and chemotherapy as the first-line treatment of advanced non-small-cell lung cancer. 

  February 13, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study. 

  February 08, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy. 

  February 08, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib. 

  February 07, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• KEYNOTE-991: pembrolizumab plus enzalutamide and androgen deprivation for metastatic hormone-sensitive prostate cancer. 

  January 27, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• The role of miRNA in prostate cancer diagnosis, prognosis and treatment response: a narrative review. 

  January 27, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Corrigendum. 

  January 25, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia. 

  January 23, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA. 

  January 20, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Trends in real-world biomarker testing and overall survival in US patients with advanced non-small-cell lung cancer. 

  January 19, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data. 

  January 19, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Use of prognostic gene expression profiling tests in primary breast cancer treatment: a German real-world patient survey. 

  January 19, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Nivolumab plus cabozantinib for advanced renal cell carcinoma. 

  January 19, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Corrigendum. 

  January 19, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trial. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• KRAS mutational analysis: a new supplementary diagnostic tool for extrahepatic biliary stenosis. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Psychological distress as risk factor for the efficacy of whole-brain radiotherapy in brain metastasis patients. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Pathogenic role of 25-hydroxycholesterol in cancer development and progression. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Receptor discordance among primary tumors, brain metastases and extra-brain metastases in patients with breast cancer. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Esophageal stenosis as an independent factor of poor prognosis in patients with ESCC treated with definitive chemoradiotherapy. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer? 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• A plain language summary of daratumumab plus lenalidomide/bortezomib/dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the GRIFFIN study. 

  January 17, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Plain Language Summary - Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return. 

  January 10, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Antiemetic use and chemotherapy induced nausea and vomiting related hospitalization costs after highly or moderately emetogenic chemotherapy. 

  January 09, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary. 

  January 09, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Testing methods to diagnose TRK fusion cancer: a plain language summary and patient perspective. 

  January 06, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]